North America Transcatheter Embolization And Occlusion Devices Market Size & Outlook

The transcatheter embolization and occlusion devices market in North America is expected to reach a projected revenue of US$ 2,423.0 million by 2030. A compound annual growth rate of 6.5% is expected of North America transcatheter embolization and occlusion devices market from 2024 to 2030.
Revenue, 2023 (US$M)
$1,561.1
Forecast, 2030 (US$M)
$2,423.0
CAGR, 2024 - 2030
6.5%
Report Coverage
North America

North America transcatheter embolization and occlusion devices market, 2018-2030 (US$M)

North

North America transcatheter embolization and occlusion devices market highlights

  • The North America transcatheter embolization and occlusion devices market generated a revenue of USD 1,561.1 million in 2023.
  • The market is expected to grow at a CAGR of 6.5% from 2024 to 2030.
  • In terms of segment, coils was the largest revenue generating product in 2023.
  • Coils is the most lucrative product segment registering the fastest growth during the forecast period.


North America data book summary

Market revenue in 2023USD 1,561.1 million
Market revenue in 2030USD 2,423.0 million
Growth rate6.5% (CAGR from 2023 to 2030)
Largest segmentCoils
Fastest growing segmentCoils
Historical data covered2018 - 2022
Base year for estimation2023
Forecast period covered2024 - 2030
Quantitative unitsRevenue in USD million
Market segmentationCoils
Key market players worldwideBoston Scientific Corp, Terumo Corp, Medtronic PLC, DePuy Synthes, Stryker Corp, Cardinal Health Inc, Abbott Laboratories, Pfizer Inc, Nordion, Sirtex Medical


Other key industry trends

  • In terms of revenue, North America region accounted for 29.4% of the global transcatheter embolization and occlusion devices market in 2023.
  • Globally, North America is projected to lead the regional market in terms of revenue in 2030.
  • Asia Pacific is the fastest growing regional market and is projected to reach USD 2,352.3 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Transcatheter Embolization and Occlusion Devices Market Scope

Transcatheter embolization and occlusion devices market segmentation & scope
Coils
Non Coils
Countries
U.S.
Canada
Germany
France
Italy
Spain
Denmark
Sweden
Norway
Japan
China
India
Australia
South Korea
Thailand
Mexico
Brazil
South Africa
Saudi Arabia
UK
Argentina
UAE
Kuwait

Transcatheter Embolization and Occlusion Devices Market Companies

Name Profile # Employees HQ Website

North America transcatheter embolization and occlusion devices market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to transcatheter embolization and occlusion devices market will help companies and investors design strategic landscapes.


Coils was the largest segment with a revenue share of 100% in 2023. Horizon Databook has segmented the North America transcatheter embolization and occlusion devices market based on coils covering the revenue growth of each sub-segment from 2018 to 2030.


Reasons to subscribe to North America transcatheter embolization and occlusion devices market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of North America transcatheter embolization and occlusion devices market databook

  • Our clientele includes a mix of transcatheter embolization and occlusion devices market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of continent-level data and insights on the North America transcatheter embolization and occlusion devices market , including forecasts for subscribers. This continent databook contains high-level insights into North America transcatheter embolization and occlusion devices market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

North America transcatheter embolization and occlusion devices market

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more